769
Views
35
CrossRef citations to date
0
Altmetric
Review

Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer

, &
Pages 131-141 | Published online: 11 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karolina Pierzynowska, Joanna Morcinek-Orłowska, Lidia Gaffke, Weronika Jaroszewicz, Piotr M. Skowron & Grzegorz Węgrzyn. (2023) Applications of the phage display technology in molecular biology, biotechnology and medicine. Critical Reviews in Microbiology 0:0, pages 1-41.
Read now
Rui Yang, Leilei Wang, Zhifeng Wu, Yongxiang Yin & Shi-Wen Jiang. (2022) How Nanotechniques Could Vitalize the O-GlcNAcylation-Targeting Approach for Cancer Therapy. International Journal of Nanomedicine 17, pages 1829-1841.
Read now

Articles from other publishers (33)

Kammila Martins Nicolau Costa, Rafaella Moreno Barros, Emmily Oliveira Jorge, Mariana Rillo Sato, Marlus Chorilli, Bolívar Ponciano Goulart de Lima Damasceno, Dean Nicholas, John F. Callan & João Augusto Oshiro Junior. (2023) Doxorubicin-loaded nanostructured lipid carriers functionalized with folic acid against MCF-7 breast cancer cell line. Journal of Nanoparticle Research 25:4.
Crossref
Tianzhong Li, Jinyong Wang, Tongkai Chen, Swelm Wageh, Ahmed A. Al-Ghamdi, Jiangtian Yu, Zhongjian Xie & Han Zhang. (2022) A hybrid of lactic acid bacteria and metal-organic frameworks potentiates photodynamic immunotherapy for hypoxia-targeted tumor eradication一种乳酸菌-金属有机框架复合物用于强化肿瘤乏氧 光动力和免疫治疗. Science China Materials 66:1, pages 363-374.
Crossref
Zhuoyue Li, Shuang Zhang, Man Liu, Ting Zhong, Hui Li, Jingru Wang, Heng Zhao, Yubo Tian, Hui Wang, Jingwen Wang, Meiqi Xu, Shumin Wang & Xuan Zhang. (2022) Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex In Vitro and In Vivo . Molecular Pharmaceutics 19:11, pages 4179-4190.
Crossref
Sk. Aminabee Aminabee, K. Indraja K. Indraja, K. Matha ManognaK. Naga Devika, K. Ramya Sri & A. Lakshmana Rao. (2022) Antioxidant and Cardioprotective Activity of Indigofera barberi on Doxorubicin Induced Toxicity on Rats. Biomedical and Pharmacology Journal 15:3, pages 1299-1309.
Crossref
Xionghui Rao, Chaojun Zhang, Huixing Luo, Jianbao Zhang, Zhehong Zhuang, Zhihao Liang & Xiaobin Wu. (2022) Targeting Gastric Cancer Stem Cells to Enhance Treatment Response. Cells 11:18, pages 2828.
Crossref
Yin Huang, Fang Yang, Linling Guo, Yan Xu, Xiaxia Yu, Zunjian Zhang & Yuxin Zhang. (2022) Plasma Pharmacokinetics and Tissue Distribution of Doxorubicin in Rats following Treatment with Astragali Radix. Pharmaceuticals 15:9, pages 1104.
Crossref
Marina de Souza Guimarães, Jorge Javier Muso Cachumba, Cecilia Zorzi Bueno, Karin Mariana Torres-Obreque, Grace Verónica Ruiz Lara, Gisele Monteiro, Leandro Ramos Souza Barbosa, Adalberto PessoaJr.Jr. & Carlota de Oliveira Rangel-Yagui. (2022) Peg-Grafted Liposomes for L-Asparaginase Encapsulation. Pharmaceutics 14:9, pages 1819.
Crossref
Rouba D. Al Bostami, Waad H. Abuwatfa & Ghaleb A. Husseini. (2022) Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy. Nanomaterials 12:15, pages 2672.
Crossref
Adeolu Z. Ogunleye, Chayanit Piyawajanusorn, Anthony Gonçalves, Ghita Ghislat & Pedro J. Ballester. (2022) Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles. Advanced Science 9:24, pages 2201501.
Crossref
Fatemeh Maghsoudinia, Hadi Akbari-Zadeh, Fahimeh Aminolroayaei, Fariba Farhadi Birgani, Ahmad Shanei & Roghayeh Kamran Samani. (2022) Ultrasound responsive Gd-DOTA/doxorubicin-loaded nanodroplet as a theranostic agent for magnetic resonance image-guided controlled release drug delivery of melanoma cancer. European Journal of Pharmaceutical Sciences 174, pages 106207.
Crossref
Mohammad Mohtasim Hamid Pial, Asahi Tomitaka, Nezih Pala & Upal Roy. (2022) Implantable Devices for the Treatment of Breast Cancer. Journal of Nanotheranostics 3:1, pages 19-38.
Crossref
Molly Brickler, Alexander Raskin & Thomas D. Ryan. (2022) Current State of Pediatric Cardio-Oncology: A Review. Children 9:2, pages 127.
Crossref
Tomasz Sikora, Karolina Morawska, Wiesław Lisowski, Paweł Rytel & Agnieszka Dylong. (2022) Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma. Pharmaceuticals 15:2, pages 112.
Crossref
Abdulrahman A. Halwani. (2022) Development of Pharmaceutical Nanomedicines: From the Bench to the Market. Pharmaceutics 14:1, pages 106.
Crossref
Kammila Martins Nicolau Costa, Luana Beatriz Camêlo de Sousa, Demis Ferreira de Melo, Diego Paulo da Silva Lima, Bolivar Ponciano Goulart de Lima Damasceno & João Augusto Oshiro-Júnior. 2022.
Inken Flörkemeier, Tamara N. Steinhauer, Nina Hedemann, Jörg Paul Weimer, Christoph Rogmans, Marion T. van Mackelenbergh, Nicolai Maass, Bernd Clement & Dirk O. Bauerschlag. (2021) High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer. Cancers 14:1, pages 2.
Crossref
L. A. Balykova, V. I. Inchina, T. V. Tarasova, L. M. Mosina, E. N. Gvozdikova, D. A. Khaydar, G. I. Myandina, S. M. Ryzhakin & I. V. Saushev. (2021) The effectiveness of liposomal doxorubicin hydrochloride in combination with cyclophosphan in the treatment of breast cancer in an experiment. Research and Practical Medicine Journal 8:4, pages 23-32.
Crossref
Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Emilia Montagna, Giuseppe Cancello, Raffaella Ghisini, Claudia Sangalli, Mara Negri, Manuelita Mazza, Monica Iorfida, Anna Cardillo, Angela Sciandivasci, Nadia Bianco, Ana Paula De Maio, Monica Milano, Giuseppe Maria Campennì, Loredana Sansonno, Giuseppe Viale, Anna Morra, Maria Cristina Leonardi, Viviana Galimberti, Paolo Veronesi & Marco Colleoni. (2021) Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial. Current Oncology 28:6, pages 5167-5178.
Crossref
Ahmed S. Abu Zaid, Ahmed E. Aleissawy, Ibrahim S. Yahia, Mahmoud A. Yassien, Nadia A. Hassouna & Khaled M. Aboshanab. (2021) Streptomyces griseus KJ623766: A Natural Producer of Two Anthracycline Cytotoxic Metabolites β- and γ-Rhodomycinone. Molecules 26:13, pages 4009.
Crossref
Rossella Basilotta, Deborah Mannino, Alessia Filippone, Giovanna Casili, Angela Prestifilippo, Lorenzo Colarossi, Gabriele Raciti, Emanuela Esposito & Michela Campolo. (2021) Role of Calixarene in Chemotherapy Delivery Strategies. Molecules 26:13, pages 3963.
Crossref
Yaelle Schilt, Tal Berman, Xiaohui Wei, Einat Nativ-Roth, Yechezkel Barenholz & Uri Raviv. (2021) Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:5, pages 129849.
Crossref
Khojasteh Ghasemi, Golnaz Vaseghi & Marjan Mansourian. (2020) Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer. Journal of Oncology Pharmacy Practice 27:2, pages 414-427.
Crossref
Martina Di Francesco, Christian Celia, Maria Chiara Cristiano, Nicola d’Avanzo, Barbara Ruozi, Constantin Mircioiu, Donato Cosco, Luisa Di Marzio & Massimo Fresta. (2021) Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer. ACS Omega 6:4, pages 2973-2989.
Crossref
Mohamad Alawak, Alice Abu Dayyih, Gihan Mahmoud, Imran Tariq, Lili Duse, Nathalie Goergen, Konrad Engelhardt, Shashank Reddy Pinnapireddy, Jarmila Jedelská, Muhannad Awak, Alexander M. König, Jana Brüßler, Jörg W. Bartsch & Udo Bakowsky. (2021) ADAM 8 as a novel target for doxorubicin delivery to TNBC cells using magnetic thermosensitive liposomes. European Journal of Pharmaceutics and Biopharmaceutics 158, pages 390-400.
Crossref
Shashank Chaturvedi & Kamla Pathak. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 299 318 .
Vito Lorusso, Agnese Latorre & Francesco Giotta. (2020) Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer. Journal of Oncology 2020, pages 1-17.
Crossref
Benjamin Steinborn & Ulrich Lächelt. (2020) Metal-organic Nanopharmaceuticals. Pharmaceutical Nanotechnology 8:3, pages 163-190.
Crossref
Vivian Doerr, Ryan N. Montalvo, Oh Sung Kwon, Erin E. Talbert, Brian A. Hain, Fraser E. Houston & Ashley J. Smuder. (2020) Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction. Antioxidants 9:3, pages 263.
Crossref
Abeer M. Alanazi, Laila Fadda, Ahlam Alhusaini, Rehab Ahmad, Iman H. Hasan & Ayman M. Mahmoud. (2020) Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants 9:2, pages 159.
Crossref
Hossein Yazdani, Esha Kaul, Ayoob Bazgir, Dusica Maysinger & Ashok Kakkar. (2020) Telodendrimer-Based Macromolecular Drug Design using 1,3-Dipolar Cycloaddition for Applications in Biology. Molecules 25:4, pages 857.
Crossref
Hassan Tamam, Jinho Park, Hytham H. Gadalla, Andrea R. Masters, Jelan A. Abdel-Aleem, Sayed I. Abdelrahman, Aly A. Abdelrahman, L. Tiffany Lyle & Yoon Yeo. (2019) Development of Liposomal Gemcitabine with High Drug Loading Capacity. Molecular Pharmaceutics 16:7, pages 2858-2871.
Crossref
Miguel Alberto, Andreas Brandl, Pankaj Kumar Garg, Safak Gül-Klein, Mathias Dahlmann, Ulrike Stein & Beate Rau. (2019) Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview. Clinical & Experimental Metastasis 36:1, pages 1-14.
Crossref
Chang Yoon, Hyoung Kim, Natalia Mishchenko, Elena Vasileva, Sergey Fedoreyev, Valentin Stonik & Jin Han. (2018) Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress. Marine Drugs 17:1, pages 2.
Crossref